Intrinsic Value
Rhythm Pharmaceuticals, Inc. (RYTM)
$43.76
+2.78 (+6.78%)
| Enterprise Value | - |
|---|---|
| Net Debt | -58.82 |
| Equity Value | - |
| Shares Outstanding | 57.67 |
| Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt